Mallinckrodt — mallinckrodt

Продукты [ править ]

Mallinckrodt имеет две основные производственные линии.

  • Продукция Specialty Pharmaceuticals включает фирменные лекарства, а также специальные дженерики и активные фармацевтические ингредиенты (API). Продукция включает биопрепараты, медицинские опиоиды , синтетические контролируемые вещества и ацетаминофен .
  • Продукция для медицинской визуализации включает контрастные вещества и радиофармпрепараты для медицинских изображений.

В четвертом квартале 2014 года на долю специализированных фармацевтических препаратов пришлось 74% чистых продаж. Основные специализированные фармацевтические продукты включают:

  • Гель Acthar , инъекционный биофармацевтический препарат, используемый для лечения детских спазмов, острых обострений рассеянного склероза и некоторых орфанных заболеваний . Маллинкродт приобрел этот продукт через приобретение Questcor Pharmaceuticals в 2014 году. Когда Questcor приобрела препарат в 2001 году, он продавал его по 40 долларов за флакон; в течение года после приобретения Questcor повысила цену на препарат до 1500 долларов за флакон и до 28000 долларов к 2013 году. В 2013 году Questcor приобрела у Novartis права на конкурирующий продукт Synacthen Depot в США. В 2014 году Маллинкродт поднял цену Acthar еще до 34 000 долларов. Федеральная торговая комиссия и генеральные прокуроры пяти штатов подали в суд на Маллинкродта за антиконкурентное поведение в отношении приобретения Synacthen Depot и монопольное ценообразование Acthar, и в январе 2017 года компания согласилась выплатить 100 миллионов долларов и лицензировать Synacthen Depot для конкурент.
  • Офирмев представляет собой запатентованную формулу ацетаминофена для внутривенного введения, используемую вместе с опиоидными обезболивающими в послеоперационном периоде.
  • Xartemis XR представляет собой пероральную комбинацию ацетаминофена и оксикодона с контролируемым высвобождением для лечения острой боли.
  • Exalgo — это гидроморфон длительного действия, принимаемый один раз в день , еще одно обезболивающее.

Ключевые универсальные специальные продукты включают:

  • Hydrocodone API и таблетки
  • Оксикодон API и таблетки
  • Таблетки с пролонгированным высвобождением метилфенидата гидрохлорида
  • Таблетки с контролируемым высвобождением сульфата декстроамфетамина
  • Другие контролируемые вещества, включая метадон и продукты, содержащие ацетаминофен

Продукты для медицинской визуализации включают Optiray ( инъекция иоверсола ), контрастное вещество на основе йодида для компьютерной томографии, и Optimark (инъекция гадоверсетамида), контрастный агент на основе гадолиния, используемый для магнитно-резонансной томографии мозга или печени.

По состоянию на 1988 г. Mallinckrodt была единственной компанией в США, которой разрешено получать кокаин, который она использовала для производства гидрохлорида кокаина , лекарственного препарата, отпускаемого по рецепту, который применялся в больницах в качестве местного анестетика врачами по лечению глаз и ушей, носа и горла .

Mallinckrodt Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Mallinckrodt Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mallinckrodt Plc backward and forwards among themselves. Mallinckrodt Plc’s institutional investor refers to the entity that pools money to purchase Mallinckrodt Plc’s securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

Security Type Shares Value

Gagnon Securities Llc
Common Shares
218.1 K

63 K

Meeder Asset Management Inc
Common Shares
3.1 K

1000

Estabrook Capital Management
Common Shares
734
213

Captrust Financial Advisors
Common Shares
557
0.0

Ifp Advisors Inc
Common Shares
8.0
0.0

Huntington National Bank
Common Shares
46.0
0.0

Steward Partners Investment Advisory Llc
Common Shares
101
0.0

Mallinckrodt Plc Technical and Predictive Indicators

Risk Adjusted Performance (0.07)
Market Risk Adjusted Performance (14.94)
Mean Deviation 6.39
Coefficient Of Variation (860.58)
Standard Deviation 9.17
Variance 84.18
Information Ratio (0.12)
Jensen Alpha (1.08)
Total Risk Alpha (1.37)
Treynor Ratio (14.95)
Maximum Drawdown 48.47
Value At Risk (16.67)
Potential Upside 15.91
Skewness 0.0347
Kurtosis 2.7
Risk Adjusted Performance (0.07)
Market Risk Adjusted Performance (14.94)
Mean Deviation 6.39
Coefficient Of Variation (860.58)
Standard Deviation 9.17
Variance 84.18
Information Ratio (0.12)
Jensen Alpha (1.08)
Total Risk Alpha (1.37)
Treynor Ratio (14.95)
Maximum Drawdown 48.47
Value At Risk (16.67)
Potential Upside 15.91
Skewness 0.0347
Kurtosis 2.7

ТОП акций на американском премаркете Lyft, Celgene, Tesla

    • 26 августа 2019, 16:32
    • |
    • Вера Абаренова

Celgene (CELG) +3,65%Amgen Inc. договорилась о покупке у Celgene Corp. прав на препарат «Отесла», предназначенный для лечения псориаза, за 13,4 млрд долларов с оплатой денежными средствами. Эта сделка станет еще одним шагом, приближающим объединение Celgene с фармацевтической корпорацией Bristol-Myers Squibb Co.

Tesla (TSLA) +1,2% планирует поднять цены в Китае на этой неделе, согласно сообщению Reuters. Кроме того, автопроизводитель рассматривает возможность очередного повышения в декабре, если вступят в силу китайские тарифы на автомобили, произведенные в США.Walt Disney (DIS) +1,7% откроет свои магазины в 25 гипермаркетах Target в октябре и планирует запустить еще 40 «магазинов в магазине» к октябрю 2020 года

Первые точки будут в крупных городах, включая Филадельфию, Денвер и Чикаго.
Mallinckrodt (MNK) +1,87% Согласно сообщению Wall Street Journal, производитель наркотических веществ Mallinckrodt находится под пристальным вниманием за его роль в опиоидном кризисе. В документе отмечается, что основная часть внимания, связанного с опиоидами, была сосредоточена на производителе OxyContin Purdue Pharma, но другие производители наркотиков, такие как Mallinckrodt, привлекают все больше внимания по мере того, как все больше юридических документов становятся публичными

( Читать дальше )

Complementary Tools for Mallinckrodt OTC Stock analysis

When running Mallinckrodt Plc price analysis, check to measure Mallinckrodt Plc’s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mallinckrodt Plc is operating at the current time. Most of Mallinckrodt Plc’s value examination focuses on studying past and present price action to predict the probability of Mallinckrodt Plc’s future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mallinckrodt Plc’s price. Additionally, you may evaluate how the addition of Mallinckrodt Plc to your portfolios can decrease your overall portfolio volatility.

Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital Go
Equity SearchSearch for activelly traded equities including funds and ETFs from over 30 global markets Go
Fund ScreenerFind activelly-traded funds from around the world traded on over 30 global exchanges Go
Bond DirectoryFind actively traded corporate debentures issued by US companies Go
Fundamental AnalysisView fundamental data based on most recent published financial statements Go
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance Go
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities Go
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins Go
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. Go
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume Go
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes Go

The market value of Mallinckrodt Plc is measured differently than its book value, which is the value of Mallinckrodt that is recorded on the company’s balance sheet. Investors also form their own opinion of Mallinckrodt Plc’s value that differs from its market value or its book value, called intrinsic value, which is Mallinckrodt Plc’s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mallinckrodt Plc’s market value can be influenced by many factors that don’t directly affect Mallinckrodt Plc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.

AltmanZ Score

Details

PiotroskiF Score

Details

BeneishM Score

Details

FinancialAnalysis

Details

Buy or SellRecommendation

Details

TechnicalAnalysis

Details

Please note, there is a significant difference between Mallinckrodt Plc’s value and its price as these two are different measures arrived at by different means. Investors typically determine Mallinckrodt Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mallinckrodt Plc’s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ТОП акций на американском премаркете Twitter, Comcast, Lyft и Mallinckrodt

    • 05 сентября 2019, 16:41
    • |
    • Вера Абаренова

Ciena (CIEN) -5% — производитель сетевого оборудования сообщил о скор квартальной прибыли в 71 цент на акцию, что на 13 центов выше прогнозной. Доходы также превзошли прогнозы Уолл-стрит. Представители Ciena заявили, что находятся на пути к значительному росту доходов и увеличению прибыльности.Lands’ End (LE) +2% — ритейлер одежды потерял 9 центов на акцию за последний квартал, что меньше потери на 19 центов на акцию, которую прогнозировали аналитики Уолл-стрит. Выручка превзошла оценки, а также продажи в соизмеримых магазинах, управляемых компанией, подскочили на 7,5%.Signet Jewelers (SIG) +26% — розничный продавец ювелирных изделий сообщил о скор. квартальной прибыли в 51 цент на акцию, что намного выше консенсус-оценки в 24 цента на акцию. Выручка превысила прогнозы, и сопоставимое падение продаж составило менее половины прогноза снижения на 3,1% аналитиками, опрошенными Refinitiv.Comcast (CMCSA) +1,4% – рейтинг материнской компании NBCUniversal и CNBC был повышен до «лучше рынка» по сравнению с «в рынке» Oppenheimer, что указывает на перспективы бизнеса широкополосного доступа и недооценку доходов от рекламы Уолл-стритом.

( Читать дальше )

Mallinckrodt Plc Historical Income Statement

Mallinckrodt Plc Income Statement is one of the three primary financial statements used for reporting Mallinckrodt’s overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Mallinckrodt Plc revenue and expense. Mallinckrodt Plc Income Statement primarily focuses on the company’s revenues and expenses during a particular period.
Income Tax ExpenseMView More Fundamentals

Consolidated Income  Earning Before Interest and Taxes EBIT  Net Income  

Add Fundamental

Revenues Cost of Revenue
Selling General and Administrative Expense Research and Development Expense
Operating Expenses Interest Expense
Income Tax Expense Net Loss Income from Discontinued Operations
Consolidated Income Net Income
Net Income Common Stock Weighted Average Shares
Weighted Average Shares Diluted Earning Before Interest and Taxes EBIT
Revenues USD Net Income Common Stock USD
Earning Before Interest and Taxes USD Gross Profit
Operating Income

Important Information & Dates

Plan and Disclosure Statement

On June 18, 2021, the Debtors filed their Joint Plan of Reorganization (together with all schedules and exhibits thereto, and as may be modified, amended, or supplemented from time to time, the «Plan») and the Disclosure Statement related thereto. On June 17, 2021, the Bankruptcy Court entered an order approving the Disclosure Statement and approving procedures for soliciting, receiving and tabulating votes on the Plan and for filing objections to the Plan, among other matters. 

Please click below to view all documents related to the Plan & Disclosure Statement:

Deadline to File Claims

The Bankruptcy Court has set the following deadlines for filing proofs of claim against the Debtors:

  • General Bar Date: February 16, 2021, at 5:00 p.m. (ET)
  • Governmental Bar Date: April 12, 2021, at 5:00 p.m. (ET)
  • Initial Administrative Claims Bar Date (for Postpetition Administrative Claims on or before April 30, 2021): June 28, 2021, at 5:00 p.m. (ET)

Click on «Submit a Claim» above to download a proof of claim form and for more information regarding filing a claim against the Debtors.

Information for Holders of Opioid Claims

The General Bar Date and the Initial Administrative Claims Bar Date in Mallinckrodt’s Chapter 11 case applies only to non-opioid claims. Opioid claims will be addressed through a separate process. Pursuant to the terms of Mallinckrodt’s amended proposed opioid settlement, opioid claims would be channeled to one or more trusts, which would receive $1.6 billion in structured payments, warrants for up to 19.99% of the reorganized debtors’ equity, and other assets. Updates will be provided at a later date regarding the process by which these trusts will be established and how opioid claims will be addressed.

If you believe you have an opioid claim, you will have the opportunity to participate in the trust process being set up pursuant to Mallinckrodt’s amended proposed opioid settlement. The General Bar Date of February 16, 2021, Governmental Bar Date of April 12, 2021, and the Initial Administrative Claims Bar Date of June 28, 2021 do not apply to opioid claims.

Hearing on First Day Motions

A hearing on the Debtors’ First Day Motions was held on October 14, 2020 and a final hearing on certain of the First Day Motions was held on November 10, 2020.Please click below to view and download the First Day Motions and the First Day Orders:

First Day MotionsFirst Day Orders

Mallinckrodt Plc September 28, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Mallinckrodt Plc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mallinckrodt Plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mallinckrodt Plc based on widely used predictive technical indicators. In general, we focus on analyzing Mallinckrodt OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mallinckrodt Plc’s daily price indicators and compare them against related drivers.

Information Ratio (0.12)
Maximum Drawdown 48.47
Value At Risk (16.67)
Potential Upside 15.91

Additionally, see Stocks Correlation. Note that the Mallinckrodt Plc information on this page should be used as a complementary analysis to other Mallinckrodt Plc’s statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Mallinckrodt plc stock price down 1.01% on Monday (Updated on September 27, 2021)

Sell candidate since 2021-09-23Gain 0.22%
PDF

The Mallinckrodt plc stock price fell by -1.01% on the last day (Monday, 27th Sep 2021) from $0.20 to $0.20. During the day the stock fluctuated 4.65% from a day low at $0.19 to a day high of $0.20. The price has fallen in 5 of the last 10 days and is down by -2% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -18 thousand shares and in total, 148 thousand shares were bought and sold for approximately $29.02 thousand.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $0.17, a level that may pose a second chance to hit a runner. According to fan-theory $0.27 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Signals & Forecast

There are mixed signals in the stock today. The Mallinckrodt plc stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.20. On a fall, the stock will find some support from the short-term average at $0.20. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, August 26, 2021, and so far it has fallen -14.41%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss

Mallinckrodt plc finds support from accumulated volume at $0.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

$0.19

$0.20

$0.20

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0089 between high and low, or 4.65%. For the last week the stock has had a daily average volatility of 5.05%.

Our recommended stop-loss:
We hold an negative evaluation for this stock. No stop-loss is set.

Is Mallinckrodt plc stock A Buy?

Mallinckrodt plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score:
-3.723

Predicted Opening Price for Mallinckrodt plc of Tuesday, September 28, 2021

The predicted opening price is based on yesterday’s movements between high, low, and the closing price.

Fair opening price September 28, 2021 Current price
$0.20 $0.20
(Undervalued)

Sell Candidate

Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On September 14, 2020 «SVB Leerink» gave «Market Perform» rating for MNK. The price target was changed from $2.00 to $1.50.

Volatility and Risk

Daily Average Volatility:
5.05 %

Overall Risk:
Very High
High
Medium
Low
Very Low

Volatility

5.05 %Daily Average Volatility

Overall Risk

Very HighHighMediumLowVery Low

Support & Resistance

Resistance: $0.20Price: $0.20Support: $0.19

Complementary Tools for Mallinckrodt OTC Stock analysis

When running Mallinckrodt Plc price analysis, check to measure Mallinckrodt Plc’s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mallinckrodt Plc is operating at the current time. Most of Mallinckrodt Plc’s value examination focuses on studying past and present price action to predict the probability of Mallinckrodt Plc’s future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mallinckrodt Plc’s price. Additionally, you may evaluate how the addition of Mallinckrodt Plc to your portfolios can decrease your overall portfolio volatility.

Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities Go
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. Go
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas Go
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency Go
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity Go
Focused OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences Go
Equity ValuationCheck real value of public entities based on technical and fundamental data Go
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes Go
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. Go
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio Go

The market value of Mallinckrodt Plc is measured differently than its book value, which is the value of Mallinckrodt that is recorded on the company’s balance sheet. Investors also form their own opinion of Mallinckrodt Plc’s value that differs from its market value or its book value, called intrinsic value, which is Mallinckrodt Plc’s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mallinckrodt Plc’s market value can be influenced by many factors that don’t directly affect Mallinckrodt Plc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.

AltmanZ Score

Details

PiotroskiF Score

Details

BeneishM Score

Details

FinancialAnalysis

Details

Buy or SellRecommendation

Details

TechnicalAnalysis

Details

Please note, there is a significant difference between Mallinckrodt Plc’s value and its price as these two are different measures arrived at by different means. Investors typically determine Mallinckrodt Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mallinckrodt Plc’s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Mallinckrodt Financial Ratios Relationships

relationshipMore Info

   Revenue   
Return On Equity Return On Asset
Profit Margin Operating Margin
Current Valuation Shares Outstanding
Shares Owned by Insiders Shares Owned by Institutions
Number of Shares Shorted Price to Sales
Revenue Gross Profit
EBITDA Net Income
Cash and Equivalents Cash per Share
Total Debt Debt to Equity
Current Ratio Cash Flow from Operations
Short Ratio Number of Employees
Beta Market Capitalization
Probability Of Bankruptcy
  Profit Margin    ( % )
Return On Equity Return On Asset
Profit Margin Operating Margin
Current Valuation Shares Outstanding
Shares Owned by Insiders Shares Owned by Institutions
Number of Shares Shorted Price to Sales
Revenue Gross Profit
EBITDA Net Income
Cash and Equivalents Cash per Share
Total Debt Debt to Equity
Current Ratio Cash Flow from Operations
Short Ratio Number of Employees
Beta Market Capitalization
Probability Of Bankruptcy

RevenuesRevenues

Mallinckrodt Plc Upcoming and Recent Events

Earnings reports are used by Mallinckrodt Plc to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Mallinckrodt Plc previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

Upcoming Quarterly Report 2nd of November 2021
Next Fiscal Quarter End 30th of September 2021